ACRS Stock Analysis: Buy, Sell, or Hold?
ACRS - Aclaris Therapeutics, Inc.
$5.63
-0.05 (-0.97%)
▼
5d:
+2.27%
30d:
+27.26%
90d:
+32.35%
HOLD
MODERATE Confidence
Analysis Updated: Jul 20, 2026 12:00 AM ET
Earnings: Aug 06, 2026
16d
Get Alerted When ACRS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ACRS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ACRS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ACRS is currently trading at $5.62, which is considered extended relative to its 30-day fair value range of $4.48 to $5.53.
Technical Outlook: Technically, ACRS is in a strong uptrend. Immediate support is located at $5.24, while resistance sits at $5.88.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+76.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ACRS is in a strong uptrend. Immediate support is located at $5.24, while resistance sits at $5.88.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+76.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.48 -
$5.53
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.1%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 76.1% below Wall St target ($10.00)
Trading Range Analysis
30-Day Trading Range
$4.48 -
$5.53
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$5.24
Resistance Level
$5.88
Current Trend
Strong Uptrend
Technical data as of
Jul 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.85
Wall Street Target
$10.00
(+76.1%)
Revenue Growth (YoY)
37.2%
Share & Embed Analysis
Last updated: July 20, 2026 2:56 PM ET
Data refreshes hourly during market hours. Next update: 3:56 PM
Data refreshes hourly during market hours. Next update: 3:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACRS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Featured in Portfolios
ACRS is a key holding in these high-performance investment strategies.
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 62 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 59 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 63 BUY |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 53 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$36 | 59 HOLD |
